ESMO 25: Live Video Event, Analyst Briefing: ESMO – What to Watch in Breast Cancer
ONCrg breast cancer analyst Carla Cabrera, PhD reviews five potentially practice-changing phase 3 readouts from ESMO 2025, spanning early HER2-positive breast cancer, first-line triple-negative disease, and...
- ESMO 2025
- Breast Cancer
- Analyst Briefing
- Video Event
- +1
